Tony Butler
Stock Analyst at Rodman & Renshaw
(0.75)
# 4,024
Out of 5,045 analysts
97
Total ratings
32.35%
Success rate
-13.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $14.05 | +78.00% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.48 | +343.55% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.33 | +1,253.38% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.10 | +614.29% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.46 | +1,642.92% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.59 | +2,602.70% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.29 | +675.19% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $61.10 | +22.75% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $95.06 | -63.18% | 7 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.63 | +9,455.66% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.65 | +687.88% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $8.76 | +470.78% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.21 | +1,139.67% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.69 | +3,498.16% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.42 | +338.60% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.56 | +52.56% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.99 | +468.56% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.81 | +4,256.96% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $10.25 | +485.37% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.99 | +11,960.30% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.44 | +1,278.04% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $3.91 | +9,107.16% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $5.76 | -65.28% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.87 | +422.65% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $0.99 | +912.66% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.72 | +303.23% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $12.27 | +796.86% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $12.25 | +7,736.73% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $14.05
Upside: +78.00%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.48
Upside: +343.55%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.33
Upside: +1,253.38%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.10
Upside: +614.29%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.46
Upside: +1,642.92%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.59
Upside: +2,602.70%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.29
Upside: +675.19%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $61.10
Upside: +22.75%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $95.06
Upside: -63.18%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.63
Upside: +9,455.66%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.65
Upside: +687.88%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $8.76
Upside: +470.78%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.21
Upside: +1,139.67%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.69
Upside: +3,498.16%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $3.42
Upside: +338.60%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $6.56
Upside: +52.56%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $2.99
Upside: +468.56%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.81
Upside: +4,256.96%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $10.25
Upside: +485.37%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.99
Upside: +11,960.30%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.44
Upside: +1,278.04%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $3.91
Upside: +9,107.16%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $5.76
Upside: -65.28%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $2.87
Upside: +422.65%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $0.99
Upside: +912.66%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $3.72
Upside: +303.23%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $12.27
Upside: +796.86%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $12.25
Upside: +7,736.73%